What this study is
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
What's being tested
- Registry
Intervention · OTHER
Patient registry
Study details
- Sponsor
- University of Kansas Medical Center
- Conditions
- Bladder Cancer
- Enrolling
- 1,000 people
- Starts
- 2017-11-02
- Est. completion
- 2035-01-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
- Patients can participate in any additional research studies during the patients' participation within this protocol.
You can't join if
- Patients who do not have presumed bladder cancer will not be eligible
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Kansas Medical Center
Kansas City, Kansas, United States
Recruiting
Study team
Sponsor
University of Kansas Medical Center
Study ID STUDY00141546
Principal investigator
John Taylor, MD
University of Kansas Medical Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.